237 related articles for article (PubMed ID: 9179085)
1. Comparison of Neoral and Sandimmune cyclosporine for induction of immunosuppression after heart transplantation.
Carrier M; White M; Pellerin M; Pelletier GB; Pelletier LC
Can J Cardiol; 1997 May; 13(5):469-73. PubMed ID: 9179085
[TBL] [Abstract][Full Text] [Related]
2. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
Roy A; Grant DR; Kneteman NM; Tchervenkov JI; Levy GA; Tan A; Hendricks L
Ann Chir; 1998; 52(8):716-21. PubMed ID: 9846420
[TBL] [Abstract][Full Text] [Related]
3. Induction of immunosuppression with rabbit antithymocyte globulin: five-year experience in cardiac transplantation.
Carrier M; Pelletier GB; Cartier R; Leclerc Y; Robitaille D; Pelletier LC
Can J Cardiol; 1993 Mar; 9(2):171-6. PubMed ID: 8490788
[TBL] [Abstract][Full Text] [Related]
4. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
Greig P; Lilly L; Scudamore C; Erb S; Yoshida E; Kneteman N; Bain V; Ghent C; Marotta P; Grant D; Wall W; Tchervenkov J; Barkun J; Roy A; Marleau D; McAlister V; Peltekian K
Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and side-effects of cyclosporine dose monitoring with levels 6 h after the morning dose in heart transplant patients.
Cantarovich M; Besner JG; Fitchett DH; Latter DA
Clin Transplant; 1997 Oct; 11(5 Pt 1):399-405. PubMed ID: 9361930
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients.
White M; Pelletier GB; Tan A; Jesina C; Carrier M
J Heart Lung Transplant; 1997 Aug; 16(8):787-94. PubMed ID: 9286770
[TBL] [Abstract][Full Text] [Related]
8. Effect of pentoxifylline on renal toxicity of cyclosporine: results of a clinical trial after heart transplantation.
Carrier M; Pelletier GB; White M; Bois D; Pelletier LC
J Heart Lung Transplant; 1996 Dec; 15(12):1179-83. PubMed ID: 8981202
[TBL] [Abstract][Full Text] [Related]
9. An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients.
Câmara NO; Dias MF; Pacheco-Silva A
Clin Transplant; 2004 Aug; 18(4):450-5. PubMed ID: 15233825
[TBL] [Abstract][Full Text] [Related]
10. Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients.
Hmiel SP; Canter C; Shepherd R; Lassa-Claxton S; Nadler M
Pediatr Transplant; 2007 Aug; 11(5):524-9. PubMed ID: 17631021
[TBL] [Abstract][Full Text] [Related]
11. OKT3 therapy increases cyclosporine blood levels.
Vasquez EM; Pollak R
Clin Transplant; 1997 Feb; 11(1):38-41. PubMed ID: 9067693
[TBL] [Abstract][Full Text] [Related]
12. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
Barnhart GR; Goldman MH; Hastillo A; Szentpetery S; Wolfgang T; Thompson J; Mohanakumar T; Katz MR; Rider S; Hanrahan J
J Heart Transplant; 1985; 4(4):381-4. PubMed ID: 3916511
[TBL] [Abstract][Full Text] [Related]
13. Comparison of generic cyclosporine microemulsion versus neoral in de novo renal transplant recipients managed by 2-hour postdose monitoring.
Sharma A; Shekhar C; Heer M; Minz M
Transplant Proc; 2006 Sep; 38(7):2051-3. PubMed ID: 16979996
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cyclosporine and tacrolimus in combination with rabbit antithymocyte immunoglobulins as induction therapy in cardiac transplantation.
Jacques F; Carrier M; Pelletier GB; Racine N; White M; Perrault LP; Pellerin M
Transplant Proc; 2009 Oct; 41(8):3337-41. PubMed ID: 19857745
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
16. A pharmacoeconomic analysis of Neoral without intravenous cyclosporine in liver transplantation in Canada.
Hemming AW; Cattral MS; Greig PD; Meisner J; Turcotte L; Lilly LB; Levy GA
Clin Transplant; 1998 Oct; 12(5):425-9. PubMed ID: 9787952
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
[TBL] [Abstract][Full Text] [Related]
18. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
19. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G
Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
[TBL] [Abstract][Full Text] [Related]
20. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
